Ion channel diseases: Episodic disorders of the nervous system

Seminars in Neurology

Volumn 19, Issue 4, 1999, Pages 363-369

  Ptáček, Louis J ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Epilepsy; Episodic disorders; Genetics; Ion channels; Migraine

Indexed keywords

ADENOSINE TRIPHOSPHATE; ION CHANNEL;

CHANNEL GATING; CHANNELOPATHY; GENE MUTATION; HEADACHE; HEART MUSCLE CELL; HUMAN; MIGRAINE; NERVE CELL EXCITABILITY; NEUROLOGIC DISEASE; PERIODIC PARALYSIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SEIZURE; SKELETAL MUSCLE;

EID: 0343938890     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1040851     Document Type: Review

References (50)

1. Ptáček LJ, Johnson KJ, Griggs RC. Genetics and physiology of the myotonic muscle disorders. N Engl J Med 1993;328:482-489
2. Fahn S. The Paroxysmal Dyskinesias. Oxford: Butterworth-Heinemann, 1994:310-345
3. Fouad GT, Servidei S, Durcan S, Bertini E, Ptáček LJ. A gene for familial paroxysmal dyskinesia (FPD1) maps to chromosome 2q. Am J Hum Genet 1996;59:135-139
4. Tawil R, Ptáček LJ, Pavlakis SG, DeVivo DC, Penn AS, Ozdemir C, Griggs RC. Andersen's syndrome: Potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features [see comments]. Ann Neurol 1994;35:326-330
5. Vahedi K, Joutel A, Van Bogaert P, Ducros A, Maciazeck J, Bach JF, et al. A gene for hereditary paroxysmal cerebellar ataxia maps to chromosome 19p [see comments]. Ann Neurol 1995; 37:289-293
6. Griggs RC, Nutt JG. Episodic ataxias as channelopathies [editorial; comment]. Ann Neurol 1995;37:285-287
7. Demirkiran M, Jankovic J. Paroxysmal dyskinesias: Clinical features and classification. Ann Neurol 1995;38:571-579
8. Hirata K, Katayama S, Saito T, Ichihashi K, Mukai T, Katayama M, et al. Paroxysmal kinesigenic choreoathetosis with abnormal electroencephalogram during attacks. Epilepsia 1991;32:492-494
9. Lombroso CT. Paroxysmal choreoathetosis: An epileptic or nonepileptic disorder? Ital J Neurol Sci 1995;16:271-277
10. Ptáček LJ. Channelopathies: Ion channels and paroxysmal disorders of the nervous system. In: Genton P, ed. Genetics of Focal Epilepsies. London: John Libbey, 1998:203-214
11. Ptáček LJ. The place of migraine as a channelopathy. Curr Opin Neurol 1998;11:217-226
12. Ptáček LJ, George AL, Jr, Griggs RC, Tawil R, Kallen RG, Barchi RL, et al. Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell 1991;67:1021-1027
13. Rojas CV, Wang JZ, Schwartz LS, Hoffman EP, Powell BR, Brown RH Jr. A Met-to-Val mutation in the skeletal muscle Na+ channel alpha-subunit in hyperkalaemic periodic paralysis. Nature 1991;354:387-389
14. Ptáček LJ, George AL, Jr., Barchi RL, et al. Mutations in an S4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita. Neuron 1992;8:891-897
15. McClatchey AI, Van den Bergh P, Pericak Vance MA, Raskind W, Verellen C, McKenna Yasek D, et al. Temperature-sensitive mutations in the III-IV cytoplasmic loop region of the skeletal muscle sodium channel gene in paramyotonia congenita. Cell 1992;68:769-774
16. Ptáček LJ, Tawil R, Griggs RC, Meola G, McManis P, Barohn RJ, et al. Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis. Neurology 1994;44:1500-1503
17. Ptáček LJ, Tawil R, Griggs RC, Engel AG, Layzer RB, Kwiecinski H, et al. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 1994;77:863-868
18. McClatchey AI, McKenna Yasek D, Cros D, Worthen HG, Kuncl RW, DeSilva SM, et al. Novel mutations in families with unusual and variable disorders of the skeletal muscle sodium channel. Nat Genet 1992;2:148-152
19. Ptáček LJ, Gouw L, Kwiecinski H, McManis P, Mendell JR, Barohn RJ, et al. Sodium channel mutations in paramyotonia congenita and hyperkalemic periodic paralysis. Ann Neurol 1993;33:300-307
20. Rosenfeld J, Sloan-Brown K, George AL Jr. A novel muscle sodium channel mutation causes painful congenital myotonia. Ann Neurol 1997;42:811-814
21. Plassart-Schiess E, Lhuillier L, George AL Jr., Fontaine B, Tabti N. Functional expression of the Ile693Thr Na+ channel mutation associated with paramyotonia congenita in a human cell line. J Physiol (Lond) 1998;507:721-727
22. Green DS, George AL, Jr, Cannon SC. Human sodium channel gating defects caused by missense mutations in S6 segments associated with myotonia: S804F and V12931. J Physiol (Lond) 1998;510:685-694
23. Wagner S, Lerche H, Mitrovic N, Heine R, George AL, Lehmann-Horn F. A novel sodium channel mutation causing a hyperkalemic paralytic and paramyotonic syndrome with variable clinical expressivity. Neurology 1997;49:1018-1025
24. Wang J, Dubowitz V, Lehmann Horn F, Ricker K, Ptáček L, Hoffman EP. In vivo sodium channel structure/function studies: Consecutive Arg1448 changes to Cys, His, and Pro at the extracellular surface of IVS4. Soc Gen Physiol Ser 1995; 50:77-88
25. Cummins TR, Zhou J, Sigworth FJ, et al. Functional consequences of a Na+ channel mutation causing hyperkalemic periodic paralysis. Neuron 1993;10:667-678
26. Cannon SC, Strittmatter SM. Functional expression of sodium channel mutations identified in families with periodic paralysis. Neuron 1993;10:317-326
27. Yang N, Ji S, Zhou M, et al. Sodium channel mutations in paramyotonia congenita exhibit similar biophysical phenotypes in vitro. Proc Natl Acad Sci USA 1994;91:12785-12789
28. Richmond JE, VanDeCarr D, Featherstone DE, George AL Jr., Ruben PC. Defective fast inactivation recovery and deactivation account for sodium channel myotonia in the I1160V mutant. Biophys J 1997;73:1896-1903
29. Richmond JE, Featherstone DE, Ruben PC. Human Na+ channel fast and slow inactivation in paramyotonia congenita mutants expressed in Xenopus laevis oocytes [see comments]. J Physiol (Lond) 1997;499:589-600
30. Lerche H, Heine R, Pika U, George AL Jr., Mitrovic N, Browatzki M, et al. Human sodium channel myotonia: slowed channel inactivation due to substitutions for a glycine within the III-IV linker. J Physiol (Lond) 1993;470:13-22
31. Mitrovic N, Lerche H, Heine R, Fleischhauer R, Pika-Hartlaub U, Hartlaub U, et al. Role in fast inactivation of conserved amino acids in the IV/S4-S5 loop of the human muscle Na+ channel. Neurosci Lett 1996;214:9-12
32. Fouad G, Dalakas M, Servedei S, Mendell JR, Van den Bergh P, Angelini C, et al. Genotype-phenotype correlations of DHP receptor alpha-1 gene mutations causing hypokalemic periodic paralysis. Neuromuscular Dis 1997;7:33-38
33. Fletcher CF, Lutz CM, O'Sullivan TS, Shaughnessy JD Jr., Hawkes R, Frankel WN, et al. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 1996;87:607-617
34. Burgess DL, Jones JM, Meisler MH, Noebels JL. Mutation of the Ca2+ channel beta subunit gene Cchb4 is associated with ataxia and seizures in the lethargic (lh) mouse. Cell 1997;88:385-392
35. Letts VA, Felix R, Biddlecome GH, Arikkath J, Mahaffey CL, Valenzuela A, et al. The mouse stargazer gene encodes a neuronal Ca2+-channel gamma subunit [see comments]. Nat Genet 1998;19:340-347
36. Smart SL, Lopantsev V, Zhang CL, Robbins CA, Wang H, Chiu SY, et al. Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron 1998;20:809-819
37. Singh NA, Charlier C, Stauffer D, DuPont BR, Leach RJ, Melis R, et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns [see comments]. Nat Genet 1998;18:25-29
38. Charlier C, Singh NA, Ryan SG, Lewis TB, Reus BE, Leach RJ, et al. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family [see comments]. Nat Genet 1998;18:53-55
39. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995;80:805-811
40. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995;80:795-803
41. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, Van-Raay TJ, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996;12:17-23
42. Splawski I, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, Keating MT. Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet 1997;17: 338-340
43. Browne DL, Gancher ST, Nutt JG, Brunt ER, Smith EA, Kramer P, et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1 [see comments]. Nat Genet 1994;8:136-140
44. Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SMG, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ gene CACNL1A4. Cell 1996;87:543-552
45. Croxen R, Newland C, Beeson D, Oosterhuis H, Chauplannaz G, Vincent A, et al. Mutations in different functional domains of the human muscle acetylcholine receptor alpha subunit in patients with the slow-channel congenital myasthenic syndrome. Hum Mol Genet 1997;6:767-774
46. Engel AG, Ohno K, Milone M, Wang HL, Nakano S, Bouzat C, et al. New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum Mol Genet 1996;5:1217-1227
47. Ohno K, Quiram PA, Milone M, Wang HL, Harper MC, Pruitt JN Jr., et al. Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor epsilon subunit gene: Identification and functional characterization of six new mutations. Hum Mol Genet 1997;6: 753-766
48. Gomez CM, Maselli R, Williams JM, Bhattacharyya BB. Wollmann RL, Day JW. Genetic manipulation of AChR responses suggests multiple causes of weakness in slow-channel syndrome. Ann N Y Acad Sci 1998;841:167-180
49. MacKinnon R. Determination of the subunit stoichiometry of a voltage-activated potassium channel. Nature 1991;350:232-235
50. Tawil R, McDermott MP, Brown R, et al. Randomized trials of dichlorphenamide in the periodic paralyses. Ann Neurol. In press